This session will provide a comprehensive update on the latest revisions to the FIP Basel Statements, along with an overview of how these updates fit within the broader work of the FIP Hospital Pharmacy Section and the Basel Statement Promotion Committee.

Moderator:

- Martina Francis, Lecturer, Sydney Pharmacy School, The University of Sydney; FIP HPS Programme Committee Secretary, Australia

Guests:

- Stephen Eckel, Associate Professor, UNC Eshelman School of Pharmacy, Chair, Basel Statement Promotion Committee (Hospital Pharmacy Section), USA

- Michael Stepanovic, Assistant Professor, UNC Eshelman School of Pharmacy; Co-Chair, Basel Statement Promotion Committee (Hospital Pharmacy Section), USA

- Ryan A. Forrey, President, FIP Hospital Pharmacy Section, USA

The pharmaceutical industry uses different kinds of water in their manufacturing processes. The pharmaceutical industry has a direct influence on public health and safety, thus, adhering to water quality standards becomes even more critical. A category of water used widely by this industry is WFI (Water for Injection). Traditionally, the industry has relied on distillation—a robust but costly and energy-intensive process—to produce Water for Injection (WFI) in compliance with regulatory standards. This webinar examines the advantages of advanced membrane systems for low-temperature WFI production, emphasizing improved efficiency, compliance, long term sustainability, and safety.

Chair:

- Mathew Cherian PhD, Consultant, Member IPS ExCo, USA

Co-moderator:

- Qurrotul Aini Shodiquna, IPS Liaison at FIP ECPG, Indonesia

Panellist:

- Sanjit Singh Lamba PhD, Consultant, India